Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Yasuko Hososaka"'
Autor:
Kimiko Kayashima, Yasuko Hososaka
Publikováno v:
Journal of Japan Academy of Nursing Science. 37:1-9
Publikováno v:
Journal of Japan Academy of Midwifery. 29:240-250
Autor:
Yasuko, Hososaka, Hiroko, Nukita, Yasuko, Ishii, Akihiro, Onishi, Seiji, Isonishi, Fumiyuki, Ito
Publikováno v:
Jikeikai medical journal. 60(3):17-22
article
Autor:
Hideaki Hanaki, Hidehito Matsui, Izumi Hayashi, Taiji Nakae, Keisuke Sunakawa, Yasuko Hososaka, Satoshi Iwata, Chie Yanagisawa, Yukie Yamaguchi
Publikováno v:
Journal of Infection and Chemotherapy. 12:181-184
We report here an outbreak of beta-lactam-induced vancomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA; BIVR) at one of the Cancer-Institute-affiliated hospitals in Tokyo. We examined a total of 500 strains (100 per year) of clinica
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 78:717-721
Recently, beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR) has been reported increasingly in Japan. Between 1998 and 2002, we tried to detect BIVR from 500 strains of MRSA in a cancer hospital. And the difference of the detection rate
Autor:
Yumiko Suzuki, Hideaki Hanaki, Zenzo Nagasawa, Keisuke Sunakawa, Taiji Nakae, Yasuko Hososaka, Yoshihito Otsuka, Harumi Endo
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 13(2)
Methicillin-resistant Staphylococcus aureus (MRSA) has been defined as S. aureus having the mecA gene or showing a minimum inhibitory concentration (MIC) of oxacillin higher than 4 mg/l. However, some clinical isolates are mecA-positive and oxacillin
Autor:
Hideaki Hanaki, Yasuko Hososaka, Chie Yanagisawa, Taiji Nakae, Keisuke Sunakawa, Yoshihito Otsuka, Zenzo Nagasawa
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 13(2)
The Clinical and Laboratory Standards Institute (CLSI) amended the criteria for vancomycin susceptibility and resistance of Staphylococcus aureus in 2006. The earlier criteria had established that S. aureus with minimum inhibitory concentrations (MIC
Publikováno v:
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 78(8)
Recently, beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR) has been reported increasingly in Japan. Between 1998 and 2002, we tried to detect BIVR from 500 strains of MRSA in a cancer hospital. And the difference of the detection rate
Autor:
Hideaki Hanaki, Yoshio Yamaguchi, Chie Yanagisawa, Kazuaki Uehara, Hidehito Matsui, Yukie Yamaguchi, Yasuko Hososaka, Kazunari Barada, Fumiko Sakai, Keisuke Sunakawa, Yasuko Itabashi, Koichiro Atsuda, Shinsuke Ikeda, Haruo Tanaka, Takashi Inamatsu, Ariaki Nagayama
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 11(2)
We could not detect hetero-vancomycin-intermediate resistant Staphylococcus aureus (hetero-VISA), according to the definition of hetero-VISA, from the clinical isolates of 140 methicillin-resistant S. aureus (MRSA) strains. However, 15 beta-lactam an
Autor:
Hideaki Hanaki, Keisuke Sunakawa, Satoshi Iwata, Hidehito Matsui, Yasuko Hososaka, Chie Yanagisawa, Taiji Nakae, Izumi Hayashi, Yukie Yamaguchi
Publikováno v:
Journal of Infection and Chemotherapy. 13:67
We report here an outbreak of β-lactam-induced vancomycin-resistant methicillin- resistant Staphylococcus aureus (MRSA; BIVR) at one of the Cancer-Institute-affiliated hospitals in Tokyo. We examined a total of 500 strains (100 per year) of clinical